Cable Car Capital’s Filana Therapeutics FLNA Stock Holding History

Cable Car Capital’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-53,500	Closed	-$1.2M	–	59
2023 Q4	$1.2M	Buy	+53,500	New	+$1.13M	1.25%	19

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cable Car Capital's FLNA Position: Q1 2024 in Review

Cable Car Capital sold out of Filana Therapeutics (FLNA) in Q1 2024, closing a stake of 53,500 shares — an estimated $1.2M sold.

Cable Car Capital first reported a position in FLNA in Q4 2023 and held it in 1 quarter. The position peaked at $1.2M in Q4 2023. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

Cable Car Capital reported no remaining Filana Therapeutics position as of Q1 2024 after selling out during the quarter.
Cable Car Capital sold 53,500 Filana Therapeutics shares in Q1 2024, an estimated $1.2M.
Cable Car Capital first reported a position in Filana Therapeutics in Q4 2023 and held it in 1 quarter.
Cable Car Capital's Filana Therapeutics position peaked at $1.2M in Q4 2023.
143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Cable Car Capital's 13F filing for Q1 2024, filed 15 May 2024.